GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Pharmaceutical Group Ltd (FRA:640) » Definitions » Dividend-Payout-to-FFO

China Resources Pharmaceutical Group (FRA:640) Dividend-Payout-to-FFO


View and export this data going back to 2016. Start your Free Trial

What is China Resources Pharmaceutical Group Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


China Resources Pharmaceutical Group Business Description

Traded in Other Exchanges
Address
26 Harbour Road, 41st Floor, China Resources Building, Room 4104-05, Wanchai, HKG
China Resources Pharmaceutical is the third-largest medical distributor in China by revenue. It is an integrated pharmaceutical company specializing in research and development, manufacturing, medical distribution, and retail pharmacies. As of 2023, the medical distribution business accounts for 82.6% of its total revenue. CR Pharma's manufacturing business, 17.8% of total revenue, has subsidiaries with a strong presence in traditional Chinese medicine and consumer healthcare.